Breaking News Instant updates and real-time market news.

AAPL

Apple

$156.39

0.82 (0.53%)

, CEVA

Ceva

$42.90

-2.1 (-4.67%)

09:59
08/05/17
08/05
09:59
08/05/17
09:59

Finisar seen as the 'most attractive' Apple iPhone supplier, Barron's says

With the next Apple's (AAPL) iPhone expected this fall, Wall Street is starting to speculate on the winners, with CEVA (CEVA) joining Cirrus Logic (CRUS) and Skyworks Solutions (SWKS), Tiernan Ray writes in this week's edition of Barron's. Among the most talked-about aspects of the next iPhone is augmented reality, Ray notes, adding that possible beneficiaries include Finisar (FNSR), Lumentum Holdings (LITE), II-VI (IIVI), and Viavi Solutions (VIAV). Finisar shares surged in June when it announced quarterly results that included an order for "3-D sensing," a code name for augmented reality, Barron's points out. Reference Link

AAPL

Apple

$156.39

0.82 (0.53%)

CEVA

Ceva

$42.90

-2.1 (-4.67%)

CRUS

Cirrus Logic

$57.45

-1.55 (-2.63%)

SWKS

Skyworks

$102.55

0.76 (0.75%)

FNSR

Finisar

$23.94

-1.96 (-7.57%)

LITE

Lumentum

$58.85

-3.6 (-5.76%)

IIVI

II-VI

$35.35

-0.6 (-1.67%)

VIAV

Viavi

$10.58

-0.19 (-1.76%)

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 09

    Aug

  • 09

    Aug

  • 10

    Aug

  • 10

    Aug

  • 15

    Aug

  • 29

    Aug

  • 05

    Sep

AAPL Apple
$156.39

0.82 (0.53%)

08/02/17
NEED
08/02/17
NO CHANGE
Target $175
NEED
Buy
Apple price target raised to $175 from $165 at Needham
Needham analyst Laura Martin raised her price target for Apple to $175 from $165 following Q3 results. The analyst reiterates a Buy rating on the shares and says Apple remains her top stock pick for 2017 owing to strategic position, EPS upside, falling risks, catalysts, and valuation.
08/03/17
OPCO
08/03/17
NO CHANGE
OPCO
Perform
Cirrus Logic guidance suggests no major iPhone 8 content growth,says Oppenheimer
Oppenheimer analyst Rick Schafer notes that Cirrus Logic (CRUS) reported in-line Q1 and says he believes Q2 guidance confirms his view that significant gen/gen content growth in the Apple's (AAPL) iPhone 8 is unlikely. The analyst reiterates a Perform rating on Cirrus Logic's shares.
08/03/17
BMOC
08/03/17
NO CHANGE
BMOC
Criteo should be bought on weakness, says BMO Capital
BMO Capital analyst Daniel Salmon says Criteo's (CRTO) stock declined on the company's "cautious comments" about Apple's (AAPL) "intelligent tracking prevention" rollout in September. The analyst doesn't expect Apple's initiative to be a "material disruption" for Criteo and he believes that Criteo's "network effect continues to build." He keeps a $70 price target and an Outperform rating on the shares.
08/04/17
FBCO
08/04/17
UPGRADE
Target $11.3
FBCO
Outperform
Himax upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Jerry Su upgraded Himax to Outperform from Neutral and raised his 2018 and 2019 estimates for the company citing expectations for better DDI sales and his belief that its Diffractive Optical Element, or DOE, will be used in Apple's (AAPL) upcoming iPhone. He raised his price target on Himax shares to $11.30 from $8.70.
CEVA Ceva
$42.90

-2.1 (-4.67%)

07/31/17
ROTH
07/31/17
NO CHANGE
Target $53
ROTH
Buy
CEVA price target raised to $53 from $47 at Roth Capital
Roth Capital analyst Suji Desilva raised his price target for CEVA to $53 from $47 ahead of results as he believes it represents a differentiated investment opportunity in high-margin licensing and royalty revenue, levered to growth across communications and Internet of Things applications. The analyst reiterates a Buy rating on the shares.
05/05/17
OPCO
05/05/17
NO CHANGE
Target $42
OPCO
Outperform
CEVA price target raised to $42 from $37 at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz raised his price target for CEVA to $42 from $37 as he believes the diverse opportunities for revenue upside in his model combined with operating margin expansion continuing beyond 2018 warrant a premium multiple. The analyst reiterates an Outperform rating on the shares.
05/05/17
ROTH
05/05/17
NO CHANGE
Target $47
ROTH
Buy
CEVA price target raised to $47 from $40 at Roth Capital
Roth Capital analyst Suji Desilva raised his price target for CEVA to $47 from $40 as he is encouraged by the continued licensing strength and unchanged 2017 expectation for royalty growth. The analyst reiterates a Buy rating on the shares.
06/05/17
BNCH
06/05/17
NO CHANGE
Target $50
BNCH
Buy
CEVA price target raised to $50 from $42 at Benchmark
After meeting with CEVA management, Benchmark analyst Gary Mobley raised his price target on the stock to $50 from $42, stating that his talks confirmed "robust" growth trends for both royalties and license revenue. He keeps a Buy rating on CEVA shares.
CRUS Cirrus Logic
$57.45

-1.55 (-2.63%)

07/18/17
LEHM
07/18/17
UPGRADE
Target $60
LEHM
Equal Weight
Xilinx upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Blayne Curtis upgraded Xilinx (XLNX) to Equal Weight saying he sees more downside elsewhere in the U.S. Semiconductors space. The analyst raised his price target for the shares to $60 from $53. The analyst this morning downgraded both AMD (AMD) and Cirrus Logic (CRUS) to Underweight.
07/18/17
07/18/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMD (AMD) downgraded to Underweight from Equal Weight at Barclays with analyst Blayne Curtis saying he is "unconvinced" that AMD products will gain enough traction to support the current valuation. 2. ADP (ADP) downgraded to Equal Weight from Overweight at Barclays with analyst Darrin Peller citing valuation and the potential for lingering political driven uncertainty to impact bookings growth. The analyst lowered his price target for the shares to $105 from $110. 3. Cirrus Logic (CRUS) downgraded to Underweight from Equal Weight at Barclays with analyst Blayne Curtis saying the company's content story "stalls" in fiscal year 2019. 4. FMC Corporation (FMC) downgraded to Neutral from Buy at Seaport Global with analyst Michael Harrison saying competitor Bayer recently noted high inventories of crop protection chemicals in Brazil that creates a more cautious view of FMC's second half earnings. 5. Dominion Diamond (DDC) was downgraded to Hold from Buy at Gabelli and to Market Perform from Outperform at BMO Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/02/17
OPCO
08/02/17
NO CHANGE
OPCO
Supply chain to react positively following Apple results, says Oppenheimer
Oppenheimer analyst Rick Schafer expects the Apple (AAPL) supply chain to react positively, as Apple's guidance likely implies limited impact from any possible launch/production delays. Within the company's supply chain, the analyst continues to prefer content increase stories helping insulate from any demand softness versus expectations. His top picks in the Apple supply chain are content-driven growth stories Broadcom (AVGO) and Skyworks (SWKS). Schafer remains on the sidelines on Cirrus Logic (CRUS) and Qorvo (QRVO) heading into their respective prints tomorrow.
SWKS Skyworks
$102.55

0.76 (0.75%)

07/21/17
COWN
07/21/17
NO CHANGE
Target $110
COWN
Market Perform
Skyworks $110 price target very supportable by results, says Cowen
Cowen analyst Timothy Arcuri noted Skyworks (SWKS) reported solid results as the company continued to execute well amid a soft China smartphone market. The analyst believes the timing of an OLED iPhone launch is already factored into the numbers and he believes his $110 price target is very supportable. However, he feels the Apple (AAPL) and supply chain trade is in the late innings. Arcuri maintained his Market Perform rating on Skyworks shares.
07/06/17
ARGS
07/06/17
INITIATION
ARGS
Buy
Skyworks initiated with a Buy at Argus
Argus analyst Jim Kelleher started coverage of Skyworks with a $120 price target and a Buy rating. The analyst expects the company's revenue from the IoT market to enable it to generate strong growth. He finds the stock's valuation attractive and calls the company "financially strong."
07/31/17
WELS
07/31/17
NO CHANGE
WELS
Wells Fargo downgrades Semiconductor sector to Market Weight
Wells Fargo analyst David Wong downgraded the Semiconductor sector to Market Weight from Overweight. Recent earnings reports from chip companies suggest that year-over-year growth will likely plateau or perhaps even decelerate over the next few months, Wong tells investors in a research note. He believes many chip stocks now have "elevated multiples" off calendar 2018 earnings estimates. Wong still sees good investment opportunities in some specific stocks, however, and reiterates Outperform ratings on Intel (INTC), Qualcomm (QCOM), Micron (MU), AMD (AMD), Skyworks (SWKS) and Microsemi (MSCC).
FNSR Finisar
$23.94

-1.96 (-7.57%)

06/29/17
DADA
06/29/17
INITIATION
Target $40
DADA
Buy
Finisar initiated with a Buy at DA Davidson
DA Davidson analyst Mark Kelleher started Finisar with a Buy rating and $40 price target.
06/16/17
STFL
06/16/17
NO CHANGE
STFL
Finisar fundamentals likely to bottom next month, says Stifel
After Finisar reported lower than expected Q4 revenue and provided weaker than expected Q1 guidance, Stifel analyst Patrick Newton blamed several factors for the weakness, including the company's China business and 10G softness. However, the analyst says that the stock reflects the China weakness while the company's fundamentals will probably bottom next month. He keeps a $33 price target and a Buy rating on the shares.
06/16/17
CHLM
06/16/17
NO CHANGE
Target $38
CHLM
Buy
Finisar upside drivers all coming in second half, says Craig-Hallum
Craig-Hallum analyst Richard Shannon said that despite Finisar's below consensus guidance for next quarter, the company's commentary with its Q4 report offered reasons for optimism in the second half of 2017 from a number of areas, including 3D sensing, 100G Datacom, ROADM line cards and Analog Coherent Optics. He sees a favorable risk/reward in the shares at current levels given expectations for accelerating sales growth and improving margins and keeps a Buy rating and $38 target on Finisar.
06/16/17
JEFF
06/16/17
NO CHANGE
Target $34
JEFF
Buy
Finisar's business to improve from here, says Jefferies
Jefferies analyst James Kisner says Finisar's (FNSR) weaker than expected Q1 outlook was widely expected and that the company's expectations to ship tens of millions of units for 3D sensing in the October quarter is important. In a post-earnings research note titled "Who Cares About Q1 Guidance...Here Comes 3D Sensing! Reiterate Buy," Kisner argues Finisar's business will improve from here. He believes the talk around 3D sensing is also positive for Lumentum (LITE). The analyst keeps a Buy rating on Finisar with a $34 price target.
LITE Lumentum
$58.85

-3.6 (-5.76%)

06/22/17
STFL
06/22/17
NO CHANGE
STFL
Lumentum price target raised to $73 from $53 at Stifel
Stifel analyst Patrick Newton raised his price target on Lumentum based on his research which indicates that the company has become the leader in developing 3D sensing applications. The analyst thinks that this development "sets the stage" for the company to "deliver significant earnings power over the next couple of years." He keeps a Buy rating on the stock.
06/12/17
RAJA
06/12/17
NO CHANGE
Target $70
RAJA
Strong Buy
Lumentum price target raised to $70 from $59 at Raymond James
Raymond James analyst Simon Leopold raised Lumentum's price target to $70 and maintained a Strong Buy rating based on better contributions increased confidence in its position with the majority share of VCSELs into the next iPhone, and now sees the value per phone near $4.50, up from our prior $2.50, and feels better about the prospects for a longer tail to the spending.
06/22/17
DADA
06/22/17
INITIATION
Target $77
DADA
Buy
Lumentum initiated with a Buy at DA Davidson
DA Davidson analyst Mark Kelleher initiated Lumentum with a Buy and a $77 price target saying the company is well positioned for significant growth in the optical networking market and has a significant market opportunity to supply lasers to the 3D Sensing market.
IIVI II-VI
$35.35

-0.6 (-1.67%)

07/24/17
CHLM
07/24/17
INITIATION
Target $50
CHLM
Buy
II-VI initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon started II-VI with a Buy rating, predicting that its optical assets acquired with the deal for Oclaro and the emergence of the 3D sensing market can accelerate its growth to 20% from about 5%. The analyst, who forecasts nearly $3 of EPS in FY19, but sees an upside case to $4.50, set a $50 price target on II-IVI shares.
07/26/17
RILY
07/26/17
DOWNGRADE
Target $35.75
RILY
Neutral
II-VI downgraded to Neutral from Buy at B. Riley
B. Riley analyst Dave Kang downgraded II-VI to Neutral saying Chinese optical demand remains soft while 3D sensing revenue "could be underwhelming." The analyst lowered his price target for the shares to $35.75 from $39.50.
04/06/17
BNCH
04/06/17
NO CHANGE
BNCH
Buy
II-VI recent weakness on VCSEL concerns a buying opportunity, says Benchmark
Benchmark analyst Mark Miller attributes recent weakness in shares of II-VI (IIVI) to reports on delays related to the introduction of VCSEL-based sensors for 3D imaging in Apple's (AAPL) iPhone 8 and concerns about VCSEL yield issues. Some investors think VCSELs represent a significant revenue opportunity in 2017 for II-VI, but Miller points out that II-VI management recently emphasized that its U.S. VCSEL ramp will primarily come in 2018. He actually views the reports as good news for II-VI, and potentially bad news for assumed first movers Lumentum (LITE) and Finisar (FNSR), he tells investors. Miller keeps a Buy rating on II-VI and sees the weakness as a buying opportunity.
03/16/17
BNCH
03/16/17
NO CHANGE
Target $40
BNCH
Buy
II-VI selloff a buying opportunity, says Benchmark
Benchmark analyst Mark Miller noted that a recent selloff in several optical telecom equipment stocks - including II-VI (IIVI), Lumentum (LITE), and Oclaro (OCLR) - has followed the disappointing earnings and guidance issued by Finisar (FNSR). Additionally weighing on II-VI was technical selling after its stock fell below its 50-day moving average, Miller tells investors. He said he views the selloff in II-VI as a buying opportunity and keeps a Buy rating and $40 price target on the shares.
VIAV Viavi
$10.58

-0.19 (-1.76%)

05/09/17
DADA
05/09/17
DOWNGRADE
Target $40
DADA
Neutral
Gigamon downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Mark Kelleher downgraded Gigamon to Neutral citing valuation following the recent rally. The analyst believes a sale of the company will be high on the strategic alternatives list for new activist investor Elliott Management. He lists Viavi (VIAV) and NetScout (NTCT) as possible acquirers. Should a deal happen, Kelleher expects a "lack of take-out premium." He raised his price target for Gigamon to $40.
07/21/17
RILY
07/21/17
UPGRADE
Target $14
RILY
Buy
Viavi upgraded to Buy from Neutral at B. Riley
B. Riley analyst Dave Kang upgraded Viavi to Buy and raised his price target for the shares to $14 from $8.75. The analyst believes telecom demand is starting to improve and thinks the company's 3D sensing will drive top-line growth and margin expansion.
05/05/17
JEFF
05/05/17
UPGRADE
Target $14
JEFF
Buy
Viavi upgraded to Buy from Hold at Jefferies
Jefferies analyst James Kisner upgraded Viavi Solutions (VIAV) to Buy saying the company's 3D sensing opportunity will "significantly increase" its earnings growth rate. The analyst expects Apple (AAPL) to launch an iPhone with 3D sensing in 2017, with multiple smartphone markers following suit in 2018. Viavi will remain the industry's sole supplier for the filter, the analyst contends. He upped his price target for the shares to $14 from $9.50.
05/22/17
RSBL
05/22/17
NO CHANGE
RSBL
China Telecom has begun work on Metro upgrade plan, says Rosenblatt
Rosenblatt Securities said China Telecom (CHA) has begun work on its Metro upgrade plan and the firm believes it will release tenders for both provincial and Metro in the timeframe of September to October. Companies in the optical equipment space that could benefit from China's upgrade cycle include Oclaro (OCRL), Finisar (FNSR), Lumentum (LITE), NeoPhotonics (NPTN), Acacia Communications (ACIA) and Viavi (VIAV).

TODAY'S FREE FLY STORIES

CBS

CBS

$51.75

0.14 (0.27%)

21:20
05/20/18
05/20
21:20
05/20/18
21:20
Upgrade
CBS rating change at Bernstein »

CBS upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$40.63

0.89 (2.24%)

20:40
05/20/18
05/20
20:40
05/20/18
20:40
Upgrade
Knight-Swift rating change at Stifel »

Knight-Swift upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

FOX

21st Century Fox

$37.27

-0.01 (-0.03%)

, FOXA

21st Century Fox

$37.67

-0.08 (-0.21%)

19:24
05/20/18
05/20
19:24
05/20/18
19:24
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FOX

21st Century Fox

$37.27

-0.01 (-0.03%)

FOXA

21st Century Fox

$37.67

-0.08 (-0.21%)

PG

Procter & Gamble

$73.45

-0.51 (-0.69%)

PEP

PepsiCo

$97.51

-0.45 (-0.46%)

KO

Coca-Cola

$42.18

-0.13 (-0.31%)

CBS

CBS

$51.75

0.14 (0.27%)

ROKU

Roku

$35.40

1.14 (3.33%)

LOW

Lowe's

$86.31

0.85 (0.99%)

GE

General Electric

$14.98

-0.05 (-0.33%)

WAB

Wabtec

$95.23

1.1 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

  • 23

    May

  • 12

    Jun

JHG

Janus Henderson Group

$32.43

-0.3 (-0.92%)

18:38
05/20/18
05/20
18:38
05/20/18
18:38
Hot Stocks
Janus Henderson Group announces dividend of 36c »

Janus Henderson Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHG

Philips

$43.01

0.26 (0.61%)

17:29
05/20/18
05/20
17:29
05/20/18
17:29
Hot Stocks
New data shows combined COPD treatments could help reduce annual cost of care »

At the American Thoracic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$94.26

1.37 (1.47%)

, CMCSA

Comcast

$32.72

0.3 (0.93%)

16:45
05/20/18
05/20
16:45
05/20/18
16:45
Hot Stocks
Box Office Battle: 'Deadpool 2' debuts at number 1 with $125M »

Ryan Reynolds and…

TWX

Time Warner

$94.26

1.37 (1.47%)

CMCSA

Comcast

$32.72

0.3 (0.93%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$48.60

-0.2 (-0.41%)

FOX

21st Century Fox

$37.27

-0.01 (-0.03%)

FOXA

21st Century Fox

$37.67

-0.08 (-0.21%)

LGF.A

Lionsgate

$24.27

0.3 (1.25%)

DIS

Disney

$103.94

-0.4 (-0.38%)

VIAB

Viacom

$27.24

-0.92 (-3.27%)

VIA

Viacom

$33.80

-0.75 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

TSLA

Tesla

$276.84

-7.6 (-2.67%)

16:28
05/20/18
05/20
16:28
05/20/18
16:28
Periodicals
ISS recommending Tesla shareholders split chairman, CEO role, Bloomberg says »

The largest proxy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

, SPX

S&P 500

$0.00

(0.00%)

16:23
05/20/18
05/20
16:23
05/20/18
16:23
Periodicals
China agrees to import more from U.S., no sign of $200B target, Reuters says »

China has agreed to…

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$14.98

-0.05 (-0.33%)

, WAB

Wabtec

$95.23

1.1 (1.17%)

16:19
05/20/18
05/20
16:19
05/20/18
16:19
Periodicals
GE nearing deal to merge transportation unit with Wabtec, Reuters says »

General Electric (GE) is…

GE

General Electric

$14.98

-0.05 (-0.33%)

WAB

Wabtec

$95.23

1.1 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 12

    Jun

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

, SPX

S&P 500

$0.00

(0.00%)

16:17
05/20/18
05/20
16:17
05/20/18
16:17
Periodicals
Trump administration walks back Chinese tariff plans, Axios says »

Treasury Secretary Steve…

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDS

Dillard's

$77.47

0.965 (1.26%)

16:13
05/20/18
05/20
16:13
05/20/18
16:13
Hot Stocks
Dillard's announces 10c cash dividend »

Dillard's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$6.45

-0.07 (-1.07%)

16:11
05/20/18
05/20
16:11
05/20/18
16:11
Hot Stocks
Data shows 'real-world' value of Afirma GSC in thyroid cancer diagnosis »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 12

    Jun

MCHP

Microchip

$92.80

-0.1865 (-0.20%)

, MSCC

Microsemi

$68.60

(0.00%)

15:42
05/20/18
05/20
15:42
05/20/18
15:42
Conference/Events
Microsemi to host special shareholder meeting »

Special shareholder…

MCHP

Microchip

$92.80

-0.1865 (-0.20%)

MSCC

Microsemi

$68.60

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDNG

Hardinge

$18.44

0.03 (0.16%)

15:35
05/20/18
05/20
15:35
05/20/18
15:35
Conference/Events
Hardinge to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

15:30
05/20/18
05/20
15:30
05/20/18
15:30
Conference/Events
Bravo Brio Restaurant to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, BDX

Becton Dickinson

$225.01

0.81 (0.36%)

04:55
05/20/18
05/20
04:55
05/20/18
04:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$225.01

0.81 (0.36%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

BSX

Boston Scientific

$30.46

0.13 (0.43%)

CELG

Celgene

$78.39

-1.59 (-1.99%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FGEN

FibroGen

$51.10

-0.2 (-0.39%)

GSK

GlaxoSmithKline

$40.04

-0.06 (-0.15%)

HRC

Hill-Rom

$90.58

0.86 (0.96%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

RETA

Reata Pharmaceuticals

$31.58

-0.59 (-1.83%)

OCX

OncoCyte

$2.55

0.05 (2.00%)

VVUS

VIVUS

$0.79

0.1672 (26.78%)

NBRV

Nabriva Therapeutics

$5.43

0.25 (4.83%)

MYL

Mylan

$39.65

-0.45 (-1.12%)

MASI

Masimo

$97.11

0.34 (0.35%)

TEVA

Teva

$21.23

0.12 (0.57%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

JAZZ

Jazz Pharmaceuticals

$167.60

2.55 (1.55%)

REGN

Regeneron

$301.87

-6.26 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 24

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 07

    Sep

  • 20

    Oct

  • 13

    Nov

  • 20

    Dec

CBS

CBS

$51.75

0.14 (0.27%)

, VIA

Viacom

$33.80

-0.75 (-2.17%)

13:23
05/19/18
05/19
13:23
05/19/18
13:23
Periodicals
CBS looks like a bargain, Barron's says »

In a follow-up story,…

CBS

CBS

$51.75

0.14 (0.27%)

VIA

Viacom

$33.80

-0.75 (-2.17%)

VIAB

Viacom

$27.24

-0.92 (-3.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$73.45

-0.51 (-0.69%)

, PEP

PepsiCo

$97.51

-0.45 (-0.46%)

13:10
05/19/18
05/19
13:10
05/19/18
13:10
Periodicals
Coca-Cola, PepsiCo look like bargains, Barron's says »

Investors have punished…

PG

Procter & Gamble

$73.45

-0.51 (-0.69%)

PEP

PepsiCo

$97.51

-0.45 (-0.46%)

KO

Coca-Cola

$42.18

-0.13 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$35.40

1.14 (3.33%)

10:32
05/19/18
05/19
10:32
05/19/18
10:32
Periodicals
Roku relevance worth taking note of, Barron's says »

Roku now is mostly a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

LOW

Lowe's

$86.31

0.85 (0.99%)

10:19
05/19/18
05/19
10:19
05/19/18
10:19
Periodicals
Lowe's turnaround what matters for long-term investors, Barron's says »

With Lowe's shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AAPL

Apple

$186.31

-0.69 (-0.37%)

, ZTCOY

ZTE Corp.

$0.00

(0.00%)

08:41
05/19/18
05/19
08:41
05/19/18
08:41
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$186.31

-0.69 (-0.37%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

ACIA

Acacia Communications

$32.97

0.45 (1.38%)

OCLR

Oclaro

$8.88

-0.015 (-0.17%)

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

GM

General Motors

$37.80

-0.51 (-1.33%)

F

Ford

$11.33

-0.12 (-1.05%)

FCAU

Fiat Chrysler

$21.86

-0.31 (-1.40%)

HMC

Honda

$32.98

-0.11 (-0.33%)

TM

Toyota

$136.04

-0.54 (-0.40%)

NSANY

Nissan

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

VRX

Valeant

$22.15

0.12 (0.54%)

PFE

Pfizer

$35.64

-0.07 (-0.20%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

INSY

Insys Therapeutics

$6.95

-0.37 (-5.05%)

VVUS

VIVUS

$0.79

0.1672 (26.78%)

CELG

Celgene

$78.39

-1.59 (-1.99%)

BAYRY

Bayer

$0.00

(0.00%)

GILD

Gilead

$68.01

0.41 (0.61%)

BMRN

BioMarin

$88.95

0.51 (0.58%)

MNK

Mallinckrodt

$15.70

-0.37 (-2.30%)

SHPG

Shire

$169.62

-2.18 (-1.27%)

MRK

Merck

$59.13

0.06 (0.10%)

JAZZ

Jazz Pharmaceuticals

$167.60

2.55 (1.55%)

TEVA

Teva

$21.23

0.12 (0.57%)

AZN

AstraZeneca

$36.34

-0.09 (-0.25%)

ACOR

Acorda Therapeutics

$23.65

-0.45 (-1.87%)

MYL

Mylan

$39.65

-0.45 (-1.12%)

NVS

Novartis

$77.08

-0.07 (-0.09%)

RHHBY

Roche

$0.00

(0.00%)

GALE

Galena

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 24

    May

  • 25

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 22

    Aug

  • 27

    Aug

  • 07

    Sep

  • 10

    Sep

  • 12

    Sep

  • 05

    Oct

  • 23

    Oct

  • 13

    Nov

  • 20

    Dec

  • 21

    Dec

BAYRY

Bayer

$0.00

(0.00%)

, BDX

Becton Dickinson

$225.01

0.81 (0.36%)

04:55
05/19/18
05/19
04:55
05/19/18
04:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$225.01

0.81 (0.36%)

BIIB

Biogen

$280.35

-0.34 (-0.12%)

BSX

Boston Scientific

$30.46

0.13 (0.43%)

CELG

Celgene

$78.39

-1.59 (-1.99%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FGEN

FibroGen

$51.10

-0.2 (-0.39%)

GSK

GlaxoSmithKline

$40.04

-0.06 (-0.15%)

HRC

Hill-Rom

$90.58

0.86 (0.96%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

RETA

Reata Pharmaceuticals

$31.58

-0.59 (-1.83%)

OCX

OncoCyte

$2.55

0.05 (2.00%)

VVUS

VIVUS

$0.79

0.1672 (26.78%)

NBRV

Nabriva Therapeutics

$5.43

0.25 (4.83%)

MYL

Mylan

$39.65

-0.45 (-1.12%)

MASI

Masimo

$97.11

0.34 (0.35%)

TEVA

Teva

$21.23

0.12 (0.57%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

JAZZ

Jazz Pharmaceuticals

$167.60

2.55 (1.55%)

REGN

Regeneron

$301.87

-6.26 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 24

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 07

    Sep

  • 20

    Oct

  • 13

    Nov

  • 20

    Dec

SLDB

Solid Biosciences

$21.96

-0.79 (-3.47%)

18:46
05/18/18
05/18
18:46
05/18/18
18:46
Hot Stocks
Solid Biosciences announces new preclinical data for SGT-001 »

Solid Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

, USO

United States Oil Fund

$14.43

-0.06 (-0.41%)

18:04
05/18/18
05/18
18:04
05/18/18
18:04
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.4K…

SPY

SPDR S&P 500 ETF Trust

$271.35

-0.66 (-0.24%)

USO

United States Oil Fund

$14.43

-0.06 (-0.41%)

GLD

SPDR Gold Trust

$122.42

0.06 (0.05%)

FXE

Euro Currency Trust

$113.01

-0.28 (-0.25%)

FXC

CurrencyShares Canadian Dollar Trust

$76.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$114.04

0.11 (0.10%)

18:02
05/18/18
05/18
18:02
05/18/18
18:02
Hot Stocks
Celanese raises prices for emulsion polymers and acetyls »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.